Cargando…
Correction: Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
Autores principales: | Li, Xiaolei, Wu, Zhiqiang, An, Xiaojing, Mei, Qian, Bai, Miaomiao, Hanski, Leena, Li, Xiang, Ahola, Tero, Han, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162650/ https://www.ncbi.nlm.nih.gov/pubmed/32297858 http://dx.doi.org/10.7554/eLife.57666 |
Ejemplares similares
-
Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
por: Li, Xiaolei, et al.
Publicado: (2017) -
An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks
por: Wu, Zhiqiang, et al.
Publicado: (2015) -
LRP16 Integrates into NF-κB Transcriptional Complex and Is Required for Its Functional Activation
por: Wu, Zhiqiang, et al.
Publicado: (2011) -
The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
por: Liu, Jin, et al.
Publicado: (2020) -
Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma
por: Xu, Jian, et al.
Publicado: (2021)